AMB-CHMINACA
From Wikipedia, the free encyclopedia
 |
|
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
|
|
| CAS Number | 1863066-03-8(racemate) |
| PubChem (CID) | 119026010 |
| ChemSpider | 32055578 |
| UNII | OU56JJP891 |
| Chemical and physical data | |
| Formula | C21H29N3O3 |
| Molar mass | 371.5 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
AMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid[1] that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.[2][3][4]
Legal status[edit]
AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[5]
See also[edit]
References[edit]
- ^ Akamatsu, Shigeki; Yoshida, Masashi (January 2016). "Fragmentation of synthetic cannabinoids with an isopropyl group or a tert-butyl group ionized by electron impact and electrospray". Journal of Mass Spectrometry. 51 (1): 28–32. doi:10.1002/jms.3722.
- ^ "MA-CHMINACA". Cayman Chemical. Retrieved 21 July 2015.
- ^ "MA-CHMINACA". Southern Association of Forensic Scientists. Retrieved 21 July 2015.
- ^ Samuel D Banister; et al. (July 2016). "The pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues". ACS Chemical Neuroscience. doi:10.1021/acschemneuro.6b00137.
- ^ "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Retrieved 21 July 2015.
 |
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
